创新药ETF天弘：8月25日融资净买入47.1万元，连续3日累计净买入460.77万元

Core Insights - The Tianhong Innovation Drug ETF (517380) experienced a net financing purchase of 471,000 yuan on August 25, 2025, following a trend of continuous net purchases over the past three trading days totaling 460,770 yuan [1][2]. Financing Activity Summary - On August 25, 2025, the financing balance reached 21,257,500 yuan, reflecting a 2.27% increase from the previous day [2][3]. - The financing net purchases for the preceding days were as follows: - August 22: 3,636,000 yuan - August 21: 500,800 yuan - August 20: 3,028,900 yuan - August 19: 1,014,600 yuan [2][3]. - Over the last 20 trading days, there were 13 days with net financing purchases, indicating a sustained interest in the ETF [1]. Margin Trading Overview - The total margin trading balance on August 25, 2025, was 21,257,500 yuan, with a notable increase of 47,100 yuan, marking a 2.27% change [3]. - The margin trading balance has shown significant fluctuations in the preceding days, with the highest increase recorded on August 22 at 21.20% [3]. Additional Information - Margin trading, also known as securities credit trading, involves investors borrowing funds to purchase securities or borrowing securities to sell them, facilitated by qualified securities companies [4].